Health tech SPAC deals on pause

The number of health technology groups listing by merging with special purpose acquisition companies has slowed dramatically from the start of the year. But the closing of two such deals this week shows that there is still some action to be found.

The companies involved are active in sectors that have seen a lot of attention from Spacs: telemedicine and proteomic analysis. But the slowdown in deal making, which appears to be partly a result of a possible move by the SEC to change the way it classifies Spac warrants, is clear.